How much funding has BioMap raised?

BioMap has raised $100.0M in total funding, most recently a Series A round.

Who are BioMap's investors?

BioMap's investors include Legend Capital, GGV Capital, Baidu Ventures, Lanchi Ventures, Xiang He Capital.

Where is BioMap headquartered?

BioMap is headquartered in Beijing, China.

What industry is BioMap in?

BioMap operates in Artificial Intelligence, Biotech.

BioMap

Decoding Life with AI Foundation Models

Beijing, China · Founded 2020 · $100.0M raised

Artificial Intelligence

Biotech

Headquarters: Beijing
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: biomap.com
Total Funding: $100.0M
Last Round: $100.0M Series AJul 2021
Rounds: 1

About

BioMap is an AI life sciences company pioneering large-scale foundation models for biology, best known for xTrimo — a 268-billion-parameter multimodal model trained on DNA, RNA, protein, cell, and biosystem data that achieves state-of-the-art performance across 300+ benchmarks in over 20 fields. Co-founded in 2020 by Baidu founder Robin Li and Wei Liu, the company offers BioMap OS, a closed-loop dry-wet lab discovery platform used by 800+ institutional users and 30+ leading enterprises for antibody design, drug discovery, synthetic biology, and precision medicine. BioMap operates globally with presence in both China and the United States, serving multinational pharmaceutical corporations and Fortune Global 500 companies.

Summary

BioMap is an Artificial Intelligence company based in Beijing, China, founded in 2020. It has raised $100.0M in total across 1 round, most recently a $100.0M Series A round in Jul 2021. Investors include Legend Capital, GGV Capital and Baidu Ventures.